The wound-healing assay (Fig. 2G) as well as “Transwell” and “Matrigel Transwell” assays (Fig. 2H) showed that ESM1 shRNA potently inhibited cervical cancer in vitro cell migration and invasion. This evidence concerns the gene ESM1 and cervical carcinoma.